Transcriptional regulation of the melanoma prognostic marker melastatin (TRPM1) by MITF in melanocytes and melanoma
- PMID: 14744763
- DOI: 10.1158/0008-5472.can-03-2440
Transcriptional regulation of the melanoma prognostic marker melastatin (TRPM1) by MITF in melanocytes and melanoma
Abstract
Determining the metastatic potential of intermediate thickness lesions remains a major challenge in the management of melanoma. Clinical studies have demonstrated that expression of melastatin/TRPM1 strongly predicts nonmetastatic propensity and correlates with improved outcome, leading to a national cooperative prospective study, which is ongoing currently. Similarly, the melanocytic markers MLANA/MART1 and MITF also have been shown to lose relative expression during melanoma progression. Recent studies have revealed that MITF, an essential transcription factor for melanocyte development, directly regulates expression of MLANA. This prompted examination of whether MITF also might transcriptionally regulate TRPM1 expression. The TRPM1 promoter contains multiple MITF consensus binding elements that were seen by chromatin immunoprecipitation to be occupied by endogenous MITF within melanoma cells. Endogenous TRPM1 expression responded strongly to MITF up- or down-regulation, as did TRPM1 promoter-driven reporters. In addition, MITF and TRPM1 mRNA levels were correlated tightly across a series of human melanoma cell lines. Mice homozygously mutated in MITF showed a dramatic decrease in TRPM1 expression. Finally, the slope of TRPM1 induction by MITF was particularly steep compared with other MITF target genes, suggesting it is a sensitive indicator of MITF expression and correspondingly of melanocytic differentiation. These studies identify MITF as a major transcriptional regulator of TRPM1 and suggest that its prognostic value may be linked to MITF-mediated regulation of cellular differentiation.
Similar articles
-
MLANA/MART1 and SILV/PMEL17/GP100 are transcriptionally regulated by MITF in melanocytes and melanoma.Am J Pathol. 2003 Jul;163(1):333-43. doi: 10.1016/S0002-9440(10)63657-7. Am J Pathol. 2003. PMID: 12819038 Free PMC article.
-
The correlation of TRPM1 (Melastatin) mRNA expression with microphthalmia-associated transcription factor (MITF) and other melanogenesis-related proteins in normal and pathological skin, hair follicles and melanocytic nevi.J Cutan Pathol. 2010 Apr;37 Suppl 1(Suppl 1):26-40. doi: 10.1111/j.1600-0560.2010.01504.x. J Cutan Pathol. 2010. PMID: 20482673 Free PMC article.
-
Human melastatin 1 (TRPM1) is regulated by MITF and produces multiple polypeptide isoforms in melanocytes and melanoma.Melanoma Res. 2004 Dec;14(6):509-16. doi: 10.1097/00008390-200412000-00011. Melanoma Res. 2004. PMID: 15577322
-
Melanocytes and the microphthalmia transcription factor network.Annu Rev Genet. 2004;38:365-411. doi: 10.1146/annurev.genet.38.072902.092717. Annu Rev Genet. 2004. PMID: 15568981 Review.
-
Microphthalmia-associated transcription factor in the Wnt signaling pathway.Pigment Cell Res. 2003 Jun;16(3):261-5. doi: 10.1034/j.1600-0749.2003.00039.x. Pigment Cell Res. 2003. PMID: 12753399 Review.
Cited by
-
Role of TRPM in melanocytes and melanoma.Exp Dermatol. 2012 Sep;21(9):650-4. doi: 10.1111/j.1600-0625.2012.01565.x. Exp Dermatol. 2012. PMID: 22897572 Free PMC article.
-
Microphthalmia transcription factor as a molecular marker for circulating tumor cell detection in blood of melanoma patients.Clin Cancer Res. 2006 Feb 15;12(4):1137-43. doi: 10.1158/1078-0432.CCR-05-1847. Clin Cancer Res. 2006. PMID: 16489066 Free PMC article.
-
TRPM1 mutations are associated with the complete form of congenital stationary night blindness.Mol Vis. 2010 Mar 12;16:425-37. Mol Vis. 2010. PMID: 20300565 Free PMC article.
-
LTR retroelement expansion of the human cancer transcriptome and immunopeptidome revealed by de novo transcript assembly.Genome Res. 2019 Oct;29(10):1578-1590. doi: 10.1101/gr.248922.119. Epub 2019 Sep 19. Genome Res. 2019. PMID: 31537638 Free PMC article.
-
Inducibly decreased MITF levels do not affect proliferation and phenotype switching but reduce differentiation of melanoma cells.J Cell Mol Med. 2018 Apr;22(4):2240-2251. doi: 10.1111/jcmm.13506. Epub 2018 Jan 25. J Cell Mol Med. 2018. PMID: 29369499 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases